International Journal of Applied Research
Vol. 3, Issue 6, Part D (2017)
Mitigation of injection-induced pain using 10% lidocaine spray: An observational study with cancer patients
To observe the effectiveness of dermal application of 10% lidocaine spray that is commonly used for diagnostic gastrointestinal intubation in mitigating injection-induced pain in cancer patients.
Methods: The study was carried out with cancer patients who needed at least two injections for either hematological analysis (cubital vein) or administer chemotherapy (dorsal metacarpal vein). During the first procedure the injection was performed as per the procedure (without the spray of 10% lidocaine), while during the second before the injection, lidocaine was sprayed and then the injection procedure was performed using a 22 gauge needle. Pain assessment was done on both occasions on a four point verbal rating scale (none = 0, mild pain = 1, moderate pain = 2, severe pain = 3 and extreme pain = 4). The difference in the response between the two points were tabulated and subjected to paired “t” test statistical analysis.
Results: The results indicate that spraying of 10% lidocaine significantly (p<0.0001) decreases the pain in cohorts was median cubital vein or dorsal metacarpal veins were punctured. The most important observation was that lidocaine reduced the pain by 70.5% when median cubital vein as against the 51.20% reduction observed when dorsal metacarpal vein was involved.
Conclusions: Lidocaine 10% spray was effective in reducing the injection.
How to cite this article:
Suresh Rao, Krishnaprasad, Sandhya Dinesh, Anita Crasta, Lokesh Naik, Arun George, Manjeshwar Shrinath Baliga. Mitigation of injection-induced pain using 10% lidocaine spray: An observational study with cancer patients. Int J Appl Res 2017;3(6):253-257.